Good news! Today Hai Medical (02225) endoscopy project has won the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition.

On September 22, the final evaluation of the 10th China Medical Industry Innovation Competition was successfully completed. The project "Intelligent AI Fluorescence Navigation 4K3D Endoscope Camera System" under Shanghai JINHAI MED TECH Co., Ltd. (02225) ranked fourth in the comprehensive score of the projects that have obtained product registration certificates, with a score of 72.62, and won the "Most Valuable Investment Award". Adhering to the concept of "a good competition is to give good products a good market", in order to promote the transformation of medical scientific and technological achievements, help the innovation and development of the medical industry, and build a solid bridge for industry-university-research-medical cooperation, the "Chinese Medical Equipment" magazine jointly organized the Chinese Medical Industry Innovation Competition with many industry associations, hospitals, universities, and research institutions. The competition, now in its tenth edition, has attracted attention since its launch in January, attracting more than a hundred outstanding projects to compete in fields such as medical equipment, medical technology, and medical services. The "Intelligent AI Fluorescence Navigation 4K3D Endoscope Camera System" project stood out in the entire process of the preliminary, semi-final, and final rounds with its unique innovative technology and broad application prospects, receiving high recognition and praise from professional judges, demonstrating the strong strength of JINHAI MED TECH in the medical innovation field. In recent years, JINHAI MED TECH has made significant breakthroughs in endoscope technology, covering a series of products from 4K ultra-high-definition endoscope systems to 3D and naked eye 3D image processing systems, and even to 4K fluorescence and future multispectral ultra-high-definition endoscope systems. Of particular note is the company's latest Endo Next series true 4K 3D 4MOS ultra-high-definition fluorescence endoscope system, which was successfully launched in July 2023. This endoscope system combines "4K+3D+fluorescence" three-in-one technology, providing a more accurate solution for minimally invasive surgery. Up to now, JINHAI MED TECH's 4K3D naked eye fluorescence endoscope camera system has obtained a Class II Medical Device License issued by the Shanghai Food and Drug Administration, with multiple successful practical application cases. JINHAI MED TECH's mid-term performance shows revenue of 25.937 million Singapore dollars in the first half of the year, a significant increase of 116.45% year-on-year.